SCHEMBL30920116

SCHEMBL30920116

COc1cc2c(cc1Cl)cc(C(C)=O)n2S(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOD2 Q9HC29 4/20 0.47
▸ NOD1 Q9Y239 4/20 0.47
▸ ALOX5 P09917 1/20 0.44
▸ ALDH3A1 P30838 1/20 0.43
▸ PPARG P37231 2/20 0.43
▸ PPARD Q03181 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ TSHR P16473 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ GAA P10253 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ CCR2 P41597 1/20 0.39
▸ PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27247710 1.00 NOD2 (0.47) NOD2NOD1ALOX5ALDH3A1PPARG
SCHEMBL30920825 0.86 ALDH1A1 (0.45) NOD2NOD1ALOX5ALDH3A1PPARG
SCHEMBL27246865 0.86 ALDH1A1 (0.45) NOD2NOD1ALOX5ALDH3A1PPARG
SCHEMBL18824208 0.80 NOD2 (0.47) NOD2NOD1ALDH3A1PPARGPPARD
SCHEMBL10003608 0.73 NOD2 (0.57) NOD2NOD1ALOX5PPARGPPARD
SCHEMBL31335990 0.72 KDM4E (0.50) NOD2NOD1ALDH1A1HPGDHTT
SCHEMBL10003474 0.72 NOD1 (0.46) NOD2NOD1ALOX5ALDH3A1PPARG
SCHEMBL18332143 0.72 NOD2 (0.65) NOD2NOD1ALOX5ALDH1A1TSHR
SCHEMBL10003944 0.72 NOD2 (0.44) NOD2NOD1ALOX5PPARGPPARD
SCHEMBL18851080 0.71 PPARG (0.48) ALDH3A1PPARGPPARDGAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4601635-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF Maze Therapeutics, Inc. (US) 2025-08-20 — — EP disclosed
Send feedback